Release of ADDPLAN neo Announced by ICON


Applied Clinical Trials

ICON, a provider of drug development services, announced the release of ADDPLAN® neo, providing a technology platform for design, simulation, and analysis of adaptive clinical trials. The new release combines three modules, ADDPLAN® BASE, ADDPLAN® MC, and ADDPLAN® DF to become integrated under one robust framework.

Read the full release here.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.